Jacky Law sees Roche's recent departure from PhRMA and ABPI as clear evidence that the Big Pharma model is breaking up.
Jacky Law looks at why the pharma industry has to wait for a global pandemic to be seen in a good light.
US pharma CEO salaries are still dwarfing the earnings of their European counterparts, but, with the industry and the economy currently in crisis, Jacky Law asks how long this can continue.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva